MicroBase Technology Corp.
MicroBase Technology Corp. engages in the research, design, manufacture, and sale of components and products of micro-atomization and micro-needles for medical, cosmetic and electronic applications in Taiwan. The company develops non-silicon-based micro-electro-mechanical systems. It offers industrial inkjet head; soft mist inhaler, for the treatment of chronic obstructive pulmonary disease, lowe… Read more
MicroBase Technology Corp. (3184) - Total Liabilities
Latest total liabilities as of June 2025: NT$140.58 Million TWD
Based on the latest financial reports, MicroBase Technology Corp. (3184) has total liabilities worth NT$140.58 Million TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MicroBase Technology Corp. - Total Liabilities Trend (2020–2024)
This chart illustrates how MicroBase Technology Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MicroBase Technology Corp. Competitors by Total Liabilities
The table below lists competitors of MicroBase Technology Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cell Source Inc
OTCQB:CLCS
|
USA | $19.21 Million |
|
Berkah Prima Perkasa Tbk PT
JK:BLUE
|
Indonesia | Rp7.64 Billion |
|
Pinnacle Bancshares Inc
PINK:PCLB
|
USA | $341.03 Million |
|
Procorp S.A.B. de C.V
MX:PROCORPB
|
Mexico | MX$986.91 Million |
|
GIBO Holdings Limited
NASDAQ:GIBOW
|
USA | $27.64 Million |
|
Futuretech II Acquisition Corp
NASDAQ:FTII
|
USA | $10.38 Million |
|
Desert Gold Ventures Inc
OTCQB:DAUGF
|
USA | $105.17K |
Liability Composition Analysis (2020–2024)
This chart breaks down MicroBase Technology Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MicroBase Technology Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MicroBase Technology Corp. (2020–2024)
The table below shows the annual total liabilities of MicroBase Technology Corp. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$104.31 Million | +59.90% |
| 2023-12-31 | NT$65.24 Million | -51.95% |
| 2022-12-31 | NT$135.76 Million | +0.09% |
| 2021-12-31 | NT$135.63 Million | -27.64% |
| 2020-12-31 | NT$187.43 Million | -- |